Organization · Venture Capital
Hevea Capital
Hevea Capital is an early-stage venture capital firm based in the United States, focusing on investments in decentralized finance, fintech, AI, and regulatory technology. The firm emphasizes a thesis-driven approach that leverages regulatory frameworks as strategic advantages in high-growth markets.
Overview
What Hevea Capital does
What Hevea Capital is
Hevea Capital is an early-stage venture capital firm based in the United States, focusing on investments in decentralized finance, fintech, AI, and regulatory technology. The firm emphasizes a thesis-driven approach that leverages regulatory frameworks as strategic advantages in high-growth markets.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 29, 2026
Official channels
Find Hevea Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Hevea Capital as a funder
Investment thesis
Hevea Capital believes the next generation of durable technology companies will emerge at the intersection of technology and governance, leveraging regulatory complexity as an advantage to build systems suitable for institutional adoption.
Focus narrative
Hevea Capital invests in frontier technologies, including embedded finance, AI-enabled diagnostics, regulatory technology, and digital asset infrastructure. The firm targets scalable systems that align innovation with long-term institutional relevance, focusing on global markets, particularly in LATAM and Europe, with selective exposure to Southeast Asia and MENA.
Value beyond capital
Hevea Capital offers capital, strategic insight, and access to a network spanning family offices, policy institutions, technical operators, and founders. The firm emphasizes regulatory strategy as a key component of product development and market entry, helping portfolio companies navigate complex regulatory environments.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A
- Sectors
- Fintech · AI · Healthcare · Regulatory Technology
- Regions
- Global · Latam · Europe · Southeast Asia · Mena
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 9
Portfolio context
Notable portfolio companies include: Linen App: A DeFi wallet designed to bridge traditional finance and crypto adoption. Nada Inc.: A platform offering tokenized real estate and home equity solutions. Optimism Protocol: A Layer 2 scaling solution for Ethereum that enhances transaction throughput and reduces costs. SnapDNA: A biotechnology company providing instant molecular diagnostics through portable hardware. Iris: A social investment platform that utilizes automation for investment insights. DODO Exchange: A decentralized market maker platform. Centrifuge: A fintech startup focused on unlocking liquidity for real-world assets. Aptos: A platform aimed at improving the user experience for web3 users. Ampleforth: An algorithmic stablecoin.
Common questions
What to know about Hevea Capital
Upseed classifies Hevea Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 29, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.